Publications by authors named "Xiaoqi Chen"

83 Publications

Immunogenicity and safety of an enterovirus 71 vaccine in children aged 36-71 months: A double-blind, randomised, similar vaccine-controlled, non-inferiority phase III trial.

Authors:
Yeqing Tong Xinyue Zhang Jinhua Chen Wei Chen Zhao Wang Qiong Li Kai Duan Sheng Wei Beifang Yang Xiaoai Qian Jiahong Li Lianju Hang Shaoyong Deng Xinguo Li Changfu Guo Heng Shen Yan Liu Peng Deng Tingbo Xie Qingliang Li Li Li Hongqiao Du Qunying Mao Fan Gao Weiwei Lu Xuhua Guan Jiao Huang Xiuling Li Xiaoqi Chen

EClinicalMedicine 2022 Oct 29;52:101596. Epub 2022 Jul 29.

Wuhan Institute of Biological Products Co., Ltd, Wuhan, China.

Background: The enterovirus 71 (EV71) vaccine produced by Wuhan Institute of Biological Products Co., Ltd. (WIBP) (B-EV71) has been given to children aged 6-35 months, and it has shown good safety, immunogenicity and efficacy. However, the administration of EV71 vaccine in children aged 36-71 months, which is another target population, needs further exploration.

Methods: We conducted a double-blind, randomised, controlled, non-inferiority phase III clinical trial in children aged 36-71 months, with a further comparison group of children aged 6-35 months in China. Children aged 6-71 months with no history of hand, foot and mouth disease or prior-vaccination of EV71 vaccine were eligible and recruited. Eligible participants aged 36-71 months were randomly assigned (1:1) to receive two doses of the B-EV71 vaccine (Older-B group) or the control EV71 vaccine (C-EV71 vaccine, produced by Institute of Medical Biology, Chinese Academy of Medical Sciences) (Older-C group), administered at a 30-day interval. Eligible participants aged 6-35 months were enrolled consecutively to receive two doses of the B-EV71 vaccine (Younger-B group) at a 30-day interval. Participants, investigators and those assessing outcomes were masked to the vaccine received. Non-inferiority analyses were conducted to compare the immunogenicity of EV71 vaccine in the Older-B group with that in the Older-C and Younger-B groups. Non-inferiority margins were 10% for seroconversion rate differences and 0.5 for geometric mean titre (GMT) ratios. The primary endpoints were the GMT level and seroconversion rate of anti-EV71 neutralising antibody 30 days after the second dose of vaccination. The primary analysis was performed in the per-protocol population. Safety analyses were conducted amongst participants receiving at least one dose of vaccine. This trial was registered at Chinadrugtrials.org.cn (#CTR20192345).

Findings: Between June 3 and June 30, 2020, 1600 participants were enrolled and assigned, including 625 participants in the Older-B group, 625 participants in the Older-C group and 350 participants in the Younger-B group. The seroconversion rate of anti-EV71 neutralising antibody in the Older-B group (99.66%; 95% CI: 99.18%-100.00%) was non-inferior to that of the Older-C (99.32%; 95% CI: 98.65%-99.98%) and Younger-B groups (100.00%; 95% CI: 100.00%-100.00%). The differences in seroconversion rates in the Older-B group to those in the Older-C and Younger-B groups were 0.34% (95%CI: -2.17%-2.86%) and -0.34% (95%CI: -2.78%-2.09%). The GMT of the anti-EV71 neutralising antibody in the Older-B group (693.87) was also non-inferior to that in the Older-C (289.37) and Younger-B groups (634.80). The ratios of GMTs in the Older-B group to those in the Older-C and Younger-B groups were 2.67 (95%CI: 2.00-3.00) and 1.00 (95%CI: 0.75-1.00), respectively. The incidence of any adverse event (AE) related to vaccination was similar amongst the three groups (34/625 [5.44%] in the Older-B group, 32/623 [5.14%] in the Older-C group, and 26/349 [7.45%] in the Younger-B group), with only 2 (0.57%) participants having grade 3 AEs in the Younger-B group. Fifteen (0.94%) participants from these three groups had reported serious AEs (SAEs), all of which were unrelated to vaccines.

Interpretation: EV71 vaccine produced by WIBP could extend to be administered to children aged 36-71 months against EV71 infection. However, the persistence of vaccine-induced immunities needs to be further investigated.

Funding: Hubei Province's young medical talent program (20191229), Hubei Province's young talent program (2021), Hubei Province's young public health talent program (2021); and the Wuhan Institute of Biological Products Co., Ltd.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.eclinm.2022.101596DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340505PMC
October 2022

Fuzzy decoupled-states multi-model identification of gas turbine operating variables through the use of their operating data.

Authors:
Sidali Aissat Ahmed Hafaifa Abdelhamid Iratni Nadji Hadroug XiaoQi Chen

ISA Trans 2022 Jul 12. Epub 2022 Jul 12.

Manufacturing Futures Research Institute, Faculty of Science, Engineering and Technology, Swinburne University of Technology, Australia. Electronic address:

Practically the rotating machines degradation, such as gas turbines, is due to the quality of construction and online operation of their dynamic state models, of different physical phenomena affecting these machines which cause their total malfunction. To maintain their stable operation, it is essential to correctly describe these real dynamic behaviors by reliable and robust representations, by models that can be used in monitoring and diagnostics. To achieve the performance objectives in terms of security, reliability, availability, and operating safety, this work proposes the development of a fuzzy multi-model identification approach with states decoupled from the operating variables, uploaded for monitoring a TITAN 130 turbine. This fuzzy multi-model structure with decoupled states is of interest for the monitoring of industrial systems because it adapts to the different changes in dynamic behavior of the system, makes it possible to represent the nonlinear behavior of the real system in a linear multi-model form without loss of information. In this work, through the different implementations and obtained results, this approach clearly shows how the gas turbine dynamics were reproduced when using the proposed fuzzy multi-models, thus allowing better performance when exploiting it for the synthesis of the faults diagnosis strategy for this rotating machine.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.isatra.2022.07.005DOI Listing
July 2022

Sea perch (Lateolabrax japonicus) autophagy related gene 5 promotes RGNNV infection via inhibiting RLRs-interferon signaling pathway.

Authors:
Xiaoqi Chen Wanwan Zhang Zhe Hu Kuopeng Cui Meisheng Yi Kuntong Jia

Fish Shellfish Immunol 2022 Jul 19;127:910-917. Epub 2022 Jul 19.

School of Marine Sciences, Sun Yat-sen University, Guangzhou, 510000, China; Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Zhuhai, 519000, China; Guangdong Provincial Key Laboratory of Marine Resources and Coastal Engineering, Guangzhou, 510000, China; Pearl River Estuary Marine Ecosystem Research Station, Ministry of Education, Zhuhai, 519000, China. Electronic address:

Autophagy-related gene 5 (Atg5), an essential component of autophagy machinery, is associated with innate immune responses. Here, the Atg5 of sea perch (Lateolabrax japonicus) (LjAtg5) was cloned and its role in regulating autophagy and interferon (IFN) response during red-spotted grouper nervous necrosis virus (RGNNV) infection was investigated. The LjAtg5 cDNA encoded a polypeptide of 275 amino acids with an APG5 domain, and had the closet genetic relationship with Micropterus salmoides Atg5. Autophagic detection showed LjAtg5 was conserved in inducing cell autophagy. Spatial expression analysis revealed LjAtg5 had a higher expression level in liver, brain, and kidney tissues of RGNNV-infected sea perch compared with the control group. In RGNNV-infected LJB cells, overexpression of LjAtg5 significantly increased the mRNA and protein levels of capsid protein, whereas knockdown of LjAtg5 led to the opposite effect, indicating LjAtg5 played a pro-viral role during RGNNV infection. Furthermore, dual luciferase reporter assay revealed LjAtg5 significantly suppressed the activation of sea perch type I IFN promoter in vitro, and overexpression of LjAtg5 strongly weaken the expression of genes related to the RIG-I-like receptors (RLRs) signaling pathway and IFN stimulated genes. These results suggested LjAtg5 promoted RGNNV infection by negatively regulating RLRs-IFN signaling pathway.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.fsi.2022.07.041DOI Listing
July 2022

The Capsid Protein of Nervous Necrosis Virus Antagonizes Host Type I IFN Production by a Dual Strategy to Negatively Regulate Retinoic Acid-Inducible Gene-I-like Receptor Pathways.

Authors:
Peng Jia Wanwan Zhang Yangxi Xiang Xiaobing Lu Xiaoqi Chen Hongbo Pan Meisheng Yi Kuntong Jia

J Immunol 2022 07 1;209(2):326-336. Epub 2022 Jul 1.

Guangdong Provincial Key Laboratory of Marine Resources and Coastal Engineering, Pearl River Estuary Marine Ecosystem Research Station, Ministry of Education, School of Marine Sciences, Sun Yat-sen University, Guangzhou, Guangdong, China;

Nervous necrosis virus (NNV), a highly pathogenic RNA virus, is a major pathogen in the global aquaculture industry. To efficiently infect fish, NNV must evade or subvert the host IFN for their replication; however, the precise mechanisms remain to be elucidated. In this study, we reported that capsid protein (CP) of red-spotted grouper NNV (RGNNV) suppressed the IFN antiviral response to promote RGNNV replication in brain cells, which depended on the ARM, S, and P domains of CP. CP showed an indirect or direct association with the key components of retinoic acid-inducible gene-I-like receptors signaling, TNFR-associated factor 3 (LjTRAF3) and IFN regulatory factor (LjIRF3), respectively, and degraded LjTRAF3 and LjIRF3 through the ubiquitin-proteasome pathway in HEK293T cells. Furthermore, we found that CP potentiated LjTRAF3 K48 ubiquitination degradation in a ring finger protein 114-dependent manner. LjIRF3 interacted with CP through the S domain of CP and the transcriptional activation domain or regulatory domain of LjIRF3. CP promoted LjIRF3 K48 ubiquitination degradation, leading to the reduced phosphorylation level and nuclear translocation of LjIRF3. Taken together, we demonstrated that CP inhibited type I IFN response by a dual strategy to potentiate the ubiquitination degradation of LjTRAF3 and LjIRF3. This study reveals a novel mechanism of RGNNV evading host immune response via its CP protein that will provide insights into the complex pathogenesis of NNV.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.4049/jimmunol.2100690DOI Listing
July 2022

Response to Different Oxygen Partial Pressures and Evolution Analysis of Apoptosis-Related Genes in Plateau Zokor ().

Authors:
Zhifang An Xiaoqi Chen Jimei Li

Front Genet 2022 8;13:865301. Epub 2022 Jun 8.

State Key Laboratory of Plateau Ecology and Agriculture, Qinghai University, Xining, China.

The plateau zokor () is a native species of the Qinghai-Tibet Plateau that spends its entire life underground in sealed burrows with hypoxic conditions. The present study aimed to assess the sequence characteristics of apoptosis-related genes and the response to different oxygen partial pressures (pO) in plateau zokor and Sprague-Dawley rats. The sequences of the p53-induced protein with a death domain (Pidd), p53-upregulated modulator of apoptosis (Puma), insulin-like growth factor binding protein 3 (Igfbp3), and apoptosis protease-activating factor 1 (Apaf1) were evaluated concerning homology and convergent evolution sites, and their mRNA levels were evaluated in different tissues under 14.13 (3,300 m) and 16.12 kPa (2,260 m) pO conditions. Our results showed that, (1) the sequences of the apoptosis-related genes in plateau zokor were highly similar to those of , followed by ; (2). Pidd, Puma, Igfbp3, and Apaf1 of plateau zokor were found to have five, one, two, and five convergent sites in functional domains with , respectively. Lastly (3), under low pO, the expression of and was downregulated in the lung of plateau zokors. In turn, and were upregulated in the liver and lung, and was upregulated in the skeletal muscle of plateau zokor under low pO. In Sprague-Dawley rats, low pO downregulated and expression in the liver and downregulated and in the lung and skeletal muscle separately. In contrast, low pO upregulated expression in the liver and skeletal muscle of Sprague-Dawley rats. Overall, the expression patterns of , , and showed the opposite pattern in the liver, lung, and skeletal muscle, respectively, of plateau zokor as compared with Sprague-Dawley rats. In conclusion, for the long-time adaptation to hypoxic environments, , , , and of plateau zokor underwent convergent evolution, which we believe may have led to upregulation of their levels under low oxygen partial pressures to induce apoptosis, so as to suppress tumorigenesis under hypoxic environments in plateau zokor.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.3389/fgene.2022.865301DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214310PMC
June 2022

Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously with Hepatitis B Virus Vaccine, Group A Meningococcal Polysaccharide Vaccine, Measles-Rubella Combined Vaccine and Japanese Encephalitis Vaccine: A Multi-Center, Randomized, Controlled Clinical Trial in China.

Authors:
Xiaodong Liu Shaoying Chang Ruize Wang Yanhui Xiao Fangjun Li Qing Xu Shaobai Zhang Xiao Chen Shangxiao Zhang Min Zhang Xiaoqi Chen Qingfan Cao Xiaoyu Liu Hui Wang Daihong Zhan Haiping Chen Wei Chen Jianyong Jiang Chao Zhang Haijiao Wang Lidong Gao Xuanwen Shi Xiaoming Yang Aiqiang Xu

Vaccines (Basel) 2022 Jun 2;10(6). Epub 2022 Jun 2.

Shandong Provincial Center for Disease Control and Prevention, Jinan 250014, China.

Background: The aim of this study was to investigate the immunogenicity and safety of the enterovirus 71 vaccine (EV71 vaccine) administered alone or simultaneously.

Methods: A multi-center, open-label, randomized controlled trial was performed involving 1080 healthy infants aged 6 months or 8 months from Shandong, Shanxi, Shaanxi, and Hunan provinces. These infants were divided into four simultaneous administration groups and EV71 vaccine separate administration group. Blood samples were collected from the infants before the first vaccination and after the completion of the vaccination. This trial was registered in the Clinical Trials Registry (NCT03519568).

Results: A total of 895 were included in the per-protocol analysis. The seroconversion rates of antibodies against EV71 in four simultaneous administration groups (98.44% (189/192), 94.57% (122/129), 99.47% (187/188) and 98.45% (190/193)) were non-inferior to EV71 vaccine separate administration group (97.93% [189/193]) respectively. Fever was the most common adverse event, the pairwise comparison tests showed no difference in the incidence rate of solicited, systemic or local adverse events. Three serious adverse events related to the vaccination were reported.

Conclusions: The evidence of immunogenicity and safety supports that the EV71 vaccine administered simultaneously with vaccines need to be administered during the same period of time recommended in China.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.3390/vaccines10060895DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230521PMC
June 2022

Identification and Quantification of Flavonoids in Okra ( L. Moench) and Antiproliferative Activity In Vitro of Four Main Components Identified.

Authors:
Jing Yang Xiaoqi Chen Shuaiqi Rao Yaochen Li Yunxiang Zang Biao Zhu

Metabolites 2022 May 26;12(6). Epub 2022 May 26.

Key Laboratory of Quality and Safety Control for Subtropical Fruit and Vegetable, Ministry of Agriculture and Rural Affairs, Collaborative Innovation Center for Efficient and Green Production of Agriculture in Mountainous Areas of Zhejiang Province, College of Horticulture Science, Zhejiang A & F University, Hangzhou 311300, China.

Okra is a kind of flavonoid-rich food which was reported to have a variety of health functions. Flavonoids are the major polyphenolic compounds in okra and are thought to play a role in reducing the risk of disease. The aim of this study was to isolate and identify the flavonoids composition in okra pods and explore the activity of the main flavonoids components identified on inhibiting tumor cell proliferation in vitro. Six individual flavonoids were identified by HPLC-MS/MS: quercetin-3-gentiobioside (Q3G), quercetin-3-sambubioside (Q3S), rutin, quercetin-7-glucoside (Q7G), isoquercitrin (ISO) and quercetin-3-malonylglucoside (Q3M), which were all separated well within 30 min. The analytical method was validated by the recovery of spiked samples and so on. Moreover, four main flavonoids components, namely Q3G, Q3S, ISO and Q3M, exhibited significant ( < 0.05) inhibition of NCI-N87, A375, A549 cells proliferation (25-100 μmol/L) and of HFLS-RA (200-300 μmol/L) in different levels, according to MTT method, respectively. It is demonstrated that the flavonoids components of okra exhibited a noteworthy development prospect as a possible nutraceutical dietary supplement.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.3390/metabo12060483DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228595PMC
May 2022

Clinical evaluation of the lot-to-lot consistency of an enterovirus 71 vaccine in a commercial-scale phase IV clinical trial.

Authors:
Jinhua Chen Pengfei Jin Xiaoqi Chen Qunying Mao Fanyue Meng Xinguo Li Wei Chen Meizhi Du Fan Gao Pei Liu Xiujuan Li Changfu Guo Tingbo Xie Weiwei Lu Qingliang Li Li Li Xing Yan Xiang Guo Hongqiao Du Xiuling Li Kai Duan Fengcai Zhu

Hum Vaccin Immunother 2022 Nov 17;18(5):2063630. Epub 2022 Jun 17.

Department of Vaccine Clinical Evaluation, Jiangsu Provincial Center of Disease Control and Prevention, Nanjing, Jiangsu, China.

Objective: To evaluate the immunogenicity, safety and lot-to-lot consistency of an inactivated enterovirus 71 (EV71) vaccine cultured in bioreactors with different specifications after full immunization.

Methods: A randomized, double-blind trial was performed in 3,000 children aged 6 ~ 35 months with six vaccine batches, which were prepared in 40 L and 150 L bioreactors for three consecutive batches respectively. Children were immunized on day 0 and 28, serum samples were collected on day 0 and 56, and neutralizing antibody titers were determined by the microcytopathic method. Immediate reactions were recorded within 30 min, local and systemic symptoms were recorded within 0 ~ 28 days, and serious adverse events were recorded within 6 months.

Results: After immunization with two doses of the inactivated EV71 vaccine, the neutralizing antibody GMT was 825.52 ± 4.09, and the positive conversion rate was 96.18%, with no significant difference. The 95% CI of the serum neutralizing antibody GMT ratio between the two groups after immunization with the three vaccine batches produced in the 150 L and 40 L bioreactors ranged from .67 ~ 1.5. The overall incidence of adverse reactions, mainly grade 1 reactions, for all 6 batches from 0 to 28 days after vaccination was 49.62%, with no significant difference (p = .8736). The incidence of systemic adverse reactions, primarily fever and diarrhea, was 45.14%; the incidence of local adverse reactions, primarily erythema and tenderness, was 9.43%.

Conclusion: The EV71 vaccine was highly immunogenic and safe in children aged 6-35 months, and 6 consecutive batches produced by the two bioreactors with different specifications were consistent.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1080/21645515.2022.2063630DOI Listing
November 2022

Fabrication and characterization of structurally stable pH-responsive polymeric vesicles by polymerization-induced self-assembly.

Authors:
Fen Zhang Yanling Niu Yantao Li Qian Yao Xiaoqi Chen Haijun Zhou Mengmeng Zhou Jijun Xiao

RSC Adv 2021 Aug 31;11(46):29042-29051. Epub 2021 Aug 31.

School of Materials Science and Engineering, Hebei University of Science and Technology 050018 Shijiazhuang Hebei Province China

Smart polymeric vesicles with both tertiary amine and epoxy functional groups were fabricated for the first time a reversible addition-fragmentation chain transfer dispersion polymerization approach, using (2-(diisopropylamino)ethyl methacrylate (DIPEMA) and glycidyl methacrylate (GlyMA) in an ethanol-water mixture. Monitoring of the polymerization revealed the low molecular weight distributions and the intermediate structures of spheres and worms, indicating an evolution in particle morphology. A phase diagram was constructed for reproducible fabrication of the vesicles, and copolymer composition was found to be more related to particle morphology. The vesicles exhibited superior structural stability for the cross-linking of the core through epoxydiamine chemistry, and intelligent pH responsibility due to the presence of the tertiary amine groups. The cross-linked vesicles showed good stability and reversibility during the swelling and shrinking cycles by switching the pH values, which endowed them with potential cell-like transmission functions. This research thus provides a method for producing structurally stable pH-responsive polymeric vesicles, and the reported vesicles are based on commercially available starting materials for possible industrial scale-up.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1039/d1ra05555kDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038146PMC
August 2021

Anti-CD20 therapy ameliorates β cell function and rebalances Th17/Treg cells in NOD mice.

Authors:
Min Chen Qianhui Zhang Yanhong Wei Qianqian Wan Min Xu Xiaoqi Chen

Endocrine 2022 04 24;76(1):44-52. Epub 2022 Jan 24.

Department of Rheumatology and Immunology, Zhongnan Hospital, Wuhan University, 169 Donghu Road, Wuhan, China.

Purpose: Anti-CD20 therapy delays type 1 diabetes mellitus (T1DM) progression in both nonobese diabetic (NOD) mice and new-onset patients. The mechanism is not completely defined. This study aimed to investigate the effects of anti-CD20 therapy on T helper 17 (Th17) cells and regulatory T cells (Tregs) in NOD mice. The role of B cell depletion in T1DM development was also examined.

Methods: NOD mice were randomly divided into two groups. The mice in the experimental group were treated with an anti-CD20 antibody, while the control mice were treated with an isotype-matched control antibody. After treatment, islet morphology and inflammation, Th17 and Treg cell frequencies in the pancreas and spleen, serum cytokine and anti-glutamic acid decarboxylase (GAD) antibody levels, interleukin (IL)-17A levels in the pancreas and spleen, insulin expression in islet cells and islet β cell function were measured.

Results: Decreased blood glucose and increased insulin secretion were found in the exprimental group compared with the CON group. A lower islet inflammation score was also found in the experimental group. Decreased Th17 cell and IL-17A levels and augmented Treg cell levels were found in the spleen and pancreas after anti-CD20 treatment. The serum levels of B cell activating factor (BAFF), IL-17A, IL-17F, IL-23 and anti-GAD autoantibodies were decreased in the experimental group, while higher serum levels of IL-10 and transforming growth factor (TGF)-β were found.

Conclusion: Anti-CD20 therapy might have some beneficial effects that improve β cell function by relieving islet inflammation through regulation of Th17/Treg cells and the proinflammatory/anti-inflammatory balance.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s12020-021-02965-xDOI Listing
April 2022

α-Lipoic Acid Exerts Its Antiviral Effect against Viral Hemorrhagic Septicemia Virus (VHSV) by Promoting Upregulation of Antiviral Genes and Suppressing VHSV-Induced Oxidative Stress.

Authors:
Wanwan Zhang Xiaoqi Chen Fangzhao Yu Fengquan Li Wangdong Li Meisheng Yi Kuntong Jia

Virol Sin 2021 Dec 12;36(6):1520-1531. Epub 2021 Sep 12.

School of Marine Sciences, Sun Yat-Sen University, Guangzhou, 510275, China.

Viral hemorrhagic septicemia virus (VHSV), belonging to the genus Novirhabdovirus, Rhabdoviridae family, is a causative agent of high mortality in fish and has caused significant losses to the aquaculture industry. Currently, no effective vaccines, Food and Drug Administration-approved inhibitors, or other therapeutic intervention options are available against VHSV. α-Lipoic Acid (LA), a potent antioxidant, has been proposed to have antiviral effects against different viruses. In this study, LA (CC = 472.6 μmol/L) was repurposed to exhibit antiviral activity against VHSV. In fathead minnow cells, LA significantly increased the cell viability post-VHSV infection (EC = 42.7 μmol/L), and exerted a dose-dependent inhibitory effect on VHSV induced-plaque, cytopathic effects, and VHSV glycoprotein expression. The time-of-addition assay suggested that the antiviral activity of LA occurred at viral replication stage. Survival assay revealed that LA could significantly upregulated the survival rate of VHSV-infected largemouth bass in both co-injection (38.095% vs. 1.887%, P < 0.01) and post-injection manner (38.813% vs. 8.696%, P < 0.01) compared with the control group. Additional comparative transcriptome and qRT-PCR analysis revealed LA treatment upregulated the expression of several antiviral genes, such as IRF7, Viperin, and ISG15. Moreover, LA treatment reduced VHSV-induced reactive oxygen species production in addition to Nrf2 and SOD1 expression. Taken together, these data demonstrated that LA suppressed VHSV replication by inducing antiviral genes expression and reducing VHSV-induced oxidative stress. These results suggest a new direction in the development of potential antiviral candidate drugs against VHSV infection.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s12250-021-00440-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435143PMC
December 2021

Laboratory study on behavioral responses of hybrid sturgeon, Acipenseridae, to wake flows induced by cylindrical bluff bodies.

Authors:
Wei Zha Yuhong Zeng Gabriel Katul Qian Li Xiaoguang Liu Xiaoqi Chen

Sci Total Environ 2021 Dec 2;799:149403. Epub 2021 Aug 2.

State Key Laboratory of Water Resources and Hydropower Engineering Science, Wuhan University, Wuhan 430072, China.

Interaction between flow and cylindrical-shaped structures generates coherent and periodic turbulent flow that is frequently experienced by fish in natural environments, influencing fish maneuvering and swimming stability. The current study evaluated the behavioral responses of hybrid sturgeon (Acipenser dabryanus ♀ × Acipenser baerii ♂) when interacting with the wake flows induced by a D-shaped cylinder, with diameter ranging from 2 to 6 cm. A two dimensional Particle Image Velocimetry (PIV) was used to measure the wake flows hydrodynamics induced by D-shaped cylinders, and the fish behavior was recorded by camera. Hydrodynamic space occupancy together with swimming behaviors were analyzed, and the result shows that due to the presence of lowest velocity and relatively low turbulence, the regions behind cylinder were characterized by the preferred station holding zone for fish. Sturgeon adopted distinctive swimming gaits (Kármán gaiting or spill) in response to the cylinder wake flow and the associated fish swimming kinematics differed from each other. Kármán gaiting and spill significantly depended on velocity, vorticity and Reynolds shear stress, and varied according to the ratio of turbulence length scale to standard fish length (L/L), which highlights the importance of cylinder vortex structure in influencing fish holding station and swimming stability. It is envisioned that these results can provide insights into the positions where fish may prefer to occupy in natural habitats and recommendations for the design and optimization of fish-friendly projects.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.scitotenv.2021.149403DOI Listing
December 2021

Preparation of polyacrylate/nanoemulsion composites and their adjuvant activity with OVA as the model antigen.

Authors:
Mengmeng Zhou Yutong Bi Chengyu Li Xiaoqi Chen Fen Zhang Haijun Zhou Jijun Xiao Yantao Li Xiongwei Qu

Colloids Surf B Biointerfaces 2021 Nov 30;207:112015. Epub 2021 Jul 30.

School of Materials Science and Engineering, Hebei University of Technology, 300130, Tianjin, PR China. Electronic address:

A series of polyacrylate/nanoemulsion composites were prepared to form a new kind of nanoemulsion, their particle sizes and polydispersity indices were measured. The particle sizes of the polyacrylate/nanoemulsion composites are consistent with nanoemulsions used in the system. In addition, an ELISA-specific antigen-antibody binding method was used for physical adsorption experiments on ovalbumin. Results showed that the adsorption performance of the polyacrylate/nanoemulsion system is best when the particle size was 55 nm, and the nanoemulsion content was 20 wt%, 30 wt%, or 40 wt%. Meanwhile, in order to select the optimum experimental conditions, in vivo immunity experiments in mice were carried out to analyze the adjuvant properties of ovalbumin as a model antigen. Analysis of ovalbumin-specific IgG, IgG1, and IgG2a antibody titers showed the best results when the particle size of the polyacrylate/nanoemulsion composites is 55 nm, the polyacrylate content is 0.5 wt%, and the nanoemulsion contents is 20 wt%. Meanwhile, titer analysis also showed that the polyacrylate obviously enhanced the IgG2a titer in mice. Our polyacrylate/nanoemulsion composites can both stimulate humoral and cellular immunity and have an enhanced adjuvant effect on water-soluble protein antigens.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.colsurfb.2021.112015DOI Listing
November 2021

COVID-19 infection in patients with connective tissue disease: A multicity study in Hubei province, China.

Authors:
Cong Ye Jixin Zhong Shaozhe Cai Li Dong Chuanjing Li Xiaoqiang Hou Xiaoqi Chen Anbing Zhang Wenli Chen Dongchu He Tao Zhou Guilian Shang Aichun Chu Huiling Li Qihuan Liu Bin Wu Xiangdong Yu Tao Peng Cheng Wen Gang Hong Huang Hao Huang Qin Huang Linchong Su Wenping Chen Huiqin Yang Lingli Dong

MedComm (2020) 2021 Mar 4;2(1):82-90. Epub 2021 Feb 4.

Department of Rheumatology and Immunology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei China.

Novel Coronavirus disease 2019 (COVID-19) has spread rapidly around the world. Individuals with immune dysregulation and/or on immunosuppressive therapy, such as rheumatic patients, are considered at greater risk for infections. However, the risks of patients with each subcategory of rheumatic diseases have not been reported. Here, we identified 100 rheumatic patients from 18,786 COVID-19 patients hospitalized in 23 centers affiliated to Hubei COVID-19 Rheumatology Alliance between January 1 and April 1, 2020. Demographic information, medical history, length of hospital stay, classification of disease severity, symptoms and signs, laboratory tests, disease outcome, computed tomography, and treatments information were collected. Compared to gout and ankylosing spondylitis (AS) patients, patients with connective tissue disease (CTD) tend to be more severe after COVID-19 infection (= 0.081). CTD patients also had lower lymphocyte counts, hemoglobin, and platelet counts ( values were 0.033, < 0.001, and 0.071, respectively). Hydroxychloroquine therapy and low- to medium-dose glucocorticoids before COVID-19 diagnosis reduced the progression of COVID-19 to severe/critical conditions (= 0.001 for hydroxychloroquine; = 0.006 for glucocorticoids). Our data suggests that COVID-19 in CTD patients may be more severe compared to patients with AS or gout.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1002/mco2.56DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013216PMC
March 2021

ARRDC3 as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer Based on Data Mining.

Authors:
Yanli Chen Dan Tian Xiaoqi Chen Zhi Tang Kuina Li Zhijiong Huang Yong Fu Yanying Feng Zhijun Yang

Int J Gen Med 2021 22;14:967-981. Epub 2021 Mar 22.

Department of Gynecologic Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.

Purpose: The dysregulation of arrestin domain containing 3 (ARRDC3) has an important effect on oncogenesis and tumor progression in many cancers, including renal cell carcinoma and breast cancer. However, the role of ARRDC3 in ovarian cancer (OC) has not been reported.

Methods: The present study explored the diagnostic and prognostic roles of ARRDC3 in ovarian cancer using GEPIA, ONCOMINE, GEO, and Kaplan-Meier Plotter databases for training and validation. Then, we conducted a stratified analysis for clinicopathological factors using Kaplan-Meier Plotter and GEPIA databases. To further explore the mechanisms, we also used the MIST database to visualize the protein-protein interaction network of ARRDC3 associated with OC. The gene-gene interaction network was visualized by GeneMANIA plugin in Cytoscape 3.8.0 software, and the associated co-expression genes of ARRDC3 were analyzed by the cBioPortal database. The 100 top co-expression genes chosen for gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were used by the DAVID website.

Results: A significant difference in ARRDC3 mRNA expression was found between OC and normal ovary tissues. ARRDC3 could potentially be implicated in the diagnosis of OC. A high ARRDC3 mRNA expression level was associated with poor overall survival and progression-free survival. However, no significance was reported in respect to post progression survival. Except for histology, which had no prognostic value for PPS in stratified analysis, stratified analysis of other factors had prognostic value for OS, PFS, and PPS. Interestingly, we found a positive correlation between ARRDC3 expression and CD8+ T cells, macrophages, neutrophils, and dendritic cells, indicating that ARRDC3 might be associated with immune infiltration of these immune cells. Co-expression genes enrichment analysis found that they were involved in the Renin-angiotensin system pathway.

Conclusion: Differentially expressed ARRDC3 might be a potential prognostic and diagnostic marker in Ovarian Cancer.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.2147/IJGM.S302012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997607PMC
March 2021

Aggregation Behavior of Poly(Acrylic acid-co-Octadecyl Methacrylate) and Bovine Serum Albumin in Aqueous Solutions.

Authors:
Mengmeng Zhou Yutong Bi Haijun Zhou Xiaoqi Chen Fen Zhang Yantao Li Xiongwei Qu

ChemistryOpen 2021 03 25;10(3):373-379. Epub 2021 Feb 25.

School of Materials Science and Engineering, Hebei University of Technology, 300130, Tianjin, China.

Polymer-protein complexing systems have been extensively studied because of their wide application in biomedicine and industry. Here, we studied the aggregation behavior of the hydrophobically associating water-soluble polymer poly(acrylic acid-co-octadecyl methacrylate) [P(AA-co-OMA)] prepared with nonionic surfactant as an emulsifier and bovine serum albumin (BSA) in aqueous solution. We identified the optimal composite conditions of P(AA-co-OMA) and BSA aqueous solution. We measured the zeta potential, dynamic light-scattering particle size, and surface tension of P(AA-co-OMA) and BSA mixed aqueous solution. The results showed that the aggregation behavior between the polymer and BSA relied mainly on the hydrophobic interactions between the molecules. In addition, the best compounding condition was 8 wt.% of P(AA-co-OMA) content. The structure of hydrophobically associating polymer P(AA-co-OMA) and its aggregation with BSA were characterized by Fourier-transform infrared spectroscopy. The infrared spectroscopy results identified the hydrogen bonding behavior of the amino and carboxyl groups between the polymer and BSA. This behavior was also confirmed using thermogravimetric analysis and differential scanning calorimetry. The thermal decomposition temperature and melting temperature of BSA changed before and after it was combined with the polymer. We measured the morphology of the polymer BSA aggregate with 8 % polymer content by transmission electron microscopy. The binding mechanism was investigated, as well.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1002/open.202000336DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953483PMC
March 2021

A cluster-randomized trial of workplace ergonomics and neck-specific exercise versus ergonomics and health promotion for office workers to manage neck pain - a secondary outcome analysis.

Authors:
Venerina Johnston Xiaoqi Chen Alyssa Welch Gisela Sjøgaard Tracy A Comans Megan McStea Leon Straker Markus Melloh Michelle Pereira Shaun O'Leary

BMC Musculoskelet Disord 2021 Jan 12;22(1):68. Epub 2021 Jan 12.

The University of Queensland, School of Health and Rehabilitation Sciences, St Lucia, Brisbane, Queensland, 4067, Australia.

Background: Neck pain is prevalent among office workers. This study evaluated the impact of an ergonomic and exercise training (EET) intervention and an ergonomic and health promotion (EHP) intervention on neck pain intensity among the All Workers and a subgroup of Neck Pain cases at baseline.

Methods: A 12-month cluster-randomized trial was conducted in 14 public and private organisations. Office workers aged ≥18 years working ≥30 h per week (n = 740) received an individualised workstation ergonomic intervention, followed by 1:1 allocation to the EET group (neck-specific exercise training), or the EHP group (health promotion) for 12 weeks. Neck pain intensity (scale: 0-9) was recorded at baseline, 12 weeks, and 12 months. Participants with data at these three time points were included for analysis (n = 367). Intervention group differences were analysed using generalized estimating equation models on an intention-to-treat basis and adjusted for potential confounders. Subgroup analysis was performed on neck cases reporting pain ≥3 at baseline (n = 96).

Results: The EET group demonstrated significantly greater reductions in neck pain intensity at 12 weeks compared to the EHP group for All Workers (EET: β = - 0.53 points 95% CI: - 0.84- - 0.22 [36%] and EHP: β = - 0.17 points 95% CI: - 0.47-0.13 [10.5%], p-value = 0.02) and the Neck Cases (EET: β = - 2.32 points 95% CI: - 3.09- - 1.56 [53%] and EHP: β = - 1.75 points 95% CI: - 2.35- - 1.16 [36%], p = 0.04). Reductions in pain intensity were not maintained at 12 months with no between-group differences observed in All Workers (EET: β = - 0.18, 95% CI: - 0.53-0.16 and EHP: β = - 0.14 points 95% CI: - 0.49-0.21, p = 0.53) or Neck Cases, although in both groups an overall reduction was found (EET: β = - 1.61 points 95% CI: - 2.36- - 0.89 and EHP: β = - 1.9 points 95% CI: - 2.59- - 1.20, p = 0.26).

Conclusion: EET was more effective than EHP in reducing neck pain intensity in All Workers and Neck Cases immediately following the intervention period (12 weeks) but not at 12 months, with changes at 12 weeks reaching clinically meaningful thresholds for the Neck Cases. Findings suggest the need for continuation of exercise to maintain benefits in the longer term.

Clinical Trial Registration: hACTRN12612001154897 Date of Registration: 31/10/2012.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1186/s12891-021-03945-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805092PMC
January 2021

PRMT5/Wnt4 axis promotes lymph-node metastasis and proliferation of laryngeal carcinoma.

Authors:
Nan Wang Honghong Yan Di Wu Zheng Zhao Xiaoqi Chen Qian Long Changlin Zhang Xiaohao Wang Wuguo Deng Xuekui Liu

Cell Death Dis 2020 10 15;11(10):864. Epub 2020 Oct 15.

Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.

Metastasis is the main cause of laryngeal cancer-related death; its molecular mechanism remains unknown. Here we identify protein arginine methyltransferase 5 (PRMT5) as a new metastasis-promoting factor in laryngeal carcinoma, and explore its underlying mechanism of action in regulating laryngeal cancer progression. We illustrated that PRMT5 expression was positively correlated with tumor stages, lymphatic metastasis, and unfavorable outcome. Functional assays revealed that PRMT5 promoted laryngeal carcinoma cell proliferation, migration, and invasive capacity in vitro, as well as lymph-node metastasis in vivo. The ectopic expression of PRMT5 induced EMT with downregulation of E-cadherin and upregulation of N-cadherin, snail, and MMP9. Mechanistic results revealed that the metastatic effects could be attributed to PRMT5-mediated activation of Wnt signaling, and Wnt4 is an important driver of Wnt/β-catenin signaling pathway. Wnt4 silencing could reverse PRMT5-induced cell proliferation, migration, and invasion capacities. Furthermore, inhibition of the Wnt/β-catenin signaling pathway abolished the effect of PRMT5-induced proliferation, whereas activation of the pathway enhanced the effect of PRMT5 overexpression on cell proliferation. These results demonstrated that the oncogenic role of PRMT5 could be attributed to PRMT5/Wnt4 axis-mediated activation of the Wnt/β-catenin signaling pathway. PRMT5 may serve as a novel prognostic marker and a therapeutic target for lymphatic metastasis of laryngeal carcinoma.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1038/s41419-020-03064-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566595PMC
October 2020

Epidemiology and clinical characteristics of COVID-19 in rheumatic diseases at a tertiary care hospital in Wuhan, China.

Authors:
Min Chen Yanhong Wei Qianhui Zhang Qianqian Wan Xiaoqi Chen

Clin Exp Rheumatol 2021 Mar-Apr;39(2):442-443. Epub 2020 Oct 1.

Department of Rheumatology and Immunology, Zhongnan Hospital, Wuhan University, China.

View Article and Find Full Text PDF

Download full-text PDF

 Source
April 2021

A portable assist-as-need upper-extremity hybrid exoskeleton for FES-induced muscle fatigue reduction in stroke rehabilitation.

Authors:
Ashley Stewart Christopher Pretty Xiaoqi Chen

BMC Biomed Eng 2019 19;1:30. Epub 2019 Nov 19.

Mechanical Engineering, University of Canterbury, 20 Kirkwood Ave, Upper Riccarton, Christchurch, 8041 New Zealand.

Background: Hybrid exoskeletons are a recent development which combine Functional Electrical Stimulation with actuators to improve both the mental and physical rehabilitation of stroke patients. Hybrid exoskeletons have been shown capable of reducing the weight of the actuator and improving movement precision compared to Functional Electrical Stimulation alone. However little attention has been given towards the ability of hybrid exoskeletons to reduce and manage Functional Electrical Stimulation induced fatigue or towards adapting to user ability. This work details the construction and testing of a novel assist-as-need upper-extremity hybrid exoskeleton which uses model-based Functional Electrical Stimulation control to delay Functional Electrical Stimulation induced muscle fatigue. The hybrid control is compared with Functional Electrical Stimulation only control on a healthy subject.

Results: The hybrid system produced 24° less average angle error and 13.2° less Root Mean Square Error, than Functional Electrical Stimulation on its own and showed a reduction in Functional Electrical Stimulation induced fatigue.

Conclusion: As far as the authors are aware, this is the study which provides evidence of the advantages of hybrid exoskeletons compared to use of Functional Electrical Stimulation on its own with regards to the delay of Functional Electrical Stimulation induced muscle fatigue.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1186/s42490-019-0028-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422522PMC
November 2019

COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study.

Authors:
Jixin Zhong Guifen Shen Huiqin Yang Anbin Huang Xiaoqi Chen Li Dong Bin Wu Anbin Zhang Linchong Su Xiaoqiang Hou Shulin Song Huiling Li Wenyu Zhou Tao Zhou Qin Huang Aichun Chu Zachary Braunstein Xiaoquan Rao Cong Ye Lingli Dong

Lancet Rheumatol 2020 Sep 3;2(9):e557-e564. Epub 2020 Jul 3.

Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Background: In the ongoing COVID-19 pandemic, the susceptibility of patients with rheumatic diseases to COVID-19 remains unclear. We aimed to investigate susceptibility to COVID-19 in patients with autoimmune rheumatic diseases during the ongoing COVID-19 pandemic.

Methods: We did a multicentre retrospective study of patients with autoimmune rheumatic diseases in Hubei province, the epicentre of the COVID-19 outbreak in China. Patients with rheumatic diseases were contacted through an automated telephone-based survey to investigate their susceptibility to COVID-19. Data about COVID-19 exposure or diagnosis were collected. Families with a documented history of COVID-19 exposure, as defined by having at least one family member diagnosed with COVID-19, were followed up by medical professionals to obtain detailed information, including sex, age, smoking history, past medical history, use of medications, and information related to COVID-19.

Findings: Between March 20 and March 30, 2020, 6228 patients with autoimmune rheumatic diseases were included in the study. The overall rate of COVID-19 in patients with an autoimmune rheumatic disease in our study population was 0·43% (27 of 6228 patients). We identified 42 families in which COVID-19 was diagnosed between Dec 20, 2019, and March 20, 2020, in either patients with a rheumatic disease or in a family member residing at the same physical address during the outbreak. Within these 42 families, COVID-19 was diagnosed in 27 (63%) of 43 patients with a rheumatic disease and in 28 (34%) of 83 of their family members with no rheumatic disease (adjusted odds ratio [OR] 2·68 [95% CI 1·14-6·27]; p=0·023). Patients with rheumatic disease who were taking hydroxychloroquine had a lower risk of COVID-19 infection than patients taking other disease-modifying anti-rheumatic drugs (OR 0·09 [95% CI 0·01-0·94]; p=0·044). Additionally, the risk of COVID-19 was increased with age (adjusted OR 1·04 [95%CI 1·01-1·06]; p=0·0081).

Interpretation: Patients with autoimmune rheumatic disease might be more susceptible to COVID-19 infection than the general population.

Funding: National Natural Science Foundation of China and the Tongji Hospital Clinical Research Flagship Program.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S2665-9913(20)30227-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333992PMC
September 2020

Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.

Authors:
Xiaoqi Chen Jing Jiang Yunxia Zhao Xinting Wang Chuanlei Zhang Lv Zhuan Danyang Zhang Yuling Zheng

J Exp Clin Cancer Res 2020 Jul 11;39(1):133. Epub 2020 Jul 11.

Guoyitang, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, China.

Background: Esophageal squamous cell carcinoma (ESCC) is one of the most prevalent gastrointestinal malignancies with high mortality. Circular RNAs (CircRNAs) have become a research hotspot in recent years for their vital roles in cancer development and progression. This study aims to clarify the roles of circNTRK2 and its underlying molecular mechanisms in ESCC.

Methods: The levels of circNTRK2, miR-140-3p, and nuclear receptor-interacting protein 1 (NRIP1) mRNA were examined by qRT-PCR. The cell proliferation ability was detected via CCK-8, EdU and colony formation assays. The invasion capacity was tested by using transwell assay. The apoptotic rate was evaluated through flow cytometry. The protein levels of cleaved PARP, cleaved caspase-3, E-cadherin, vimentin, and NRIP1 were measured by western blot assay. The validation of circular structure was performed by Sanger sequencing, divergent primer PCR, and RNase R treatments. The ceRNA regulatory mechanism of circNTRK2 was observed via dual-luciferase reporter, RIP and RNA pull-down assays. The mice xenograft models were constructed to confirm the oncogenicity of circNTRK2 in ESCC in vivo.

Results: CircNTRK2 was highly expressed in ESCC tissues and cells. High expression of circNTRK2 was correlated with advanced TNM stage, lymph node metastasis and short survival. Knockdown of circNTRK2 inhibited ESCC cell proliferation, invasion and epithelial-mesenchymal transition (EMT), and accelerated apoptosis in vitro. Mechanistic assays disclosed that circNTRK2 could act as a sponge for miR-140-3p to abate its suppression on target NRIP1 expression. Moreover, miR-140-3p-induced inhibitory effects on ESCC cell malignant phenotypes were attenuated by the overexpression of circNTRK2. In addition, depletion of NRIP1 impeded cell proliferation, invasion and EMT, while enhanced apoptosis. Furthermore, silencing of circNTRK2 suppressed cell proliferation and invasion through regulating NRIP1 expression. Also, knockdown of circNTRK2 slowed ESCC tumor growth in vivo.

Conclusion: CircNTRK2 promoted ESCC progression by regulating miR-140-3p/NRIP1 pathway. Our findings contribute to a better understanding of circRNAs as miRNA sponges and highlight a promising therapy target in ESCC.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1186/s13046-020-01640-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353745PMC
July 2020

Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes.

Authors:
Qianhui Zhang Yanhong Wei Min Chen Qianqian Wan Xiaoqi Chen

J Diabetes Complications 2020 10 29;34(10):107666. Epub 2020 Jun 29.

Department of Rheumatology and Immunology, Zhongnan Hospital of Wuhan University, Wuhan, China. Electronic address:

Aims: To describe characteristics of COVID-19 patients with type 2 diabetes and to analyze risk factors for severity.

Methods: Demographics, comorbidities, symptoms, laboratory findings, treatments and outcomes of COVID-19 patients with diabetes were collected and analyzed.

Results: Seventy-fourCOVID-19 patients with diabetes were included. Twenty-seven patients (36.5%) were severe and 10 patients (13.5%) died. Higher levels of blood glucose, serum amyloid A (SAA), C reactive protein and interleukin 6 were associated with severe patients compared to non-severe ones (P<0.05). Levels of albumin, cholesterol, high density lipoprotein, small and dense low density lipoprotein and CD4T lymphocyte counts in severe patients were lower than those in non-severe patients (P<0.05). Logistic regression analysis identified decreased CD4T lymphocyte counts (odds ratio [OR]=0.988, 95%Confidence interval [95%CI] 0.979-0.997) and increased SAA levels (OR=1.029, 95%CI 1.002-1.058) as risk factors for severity of COVID-19 with diabetes (P<0.05).

Conclusions: Type 2 diabetic patients were more susceptible to COVID-19 than overall population, which might be associated with hyperglycemia and dyslipidemia. Aggressive treatment should be suggested, especially when these patients had low CD4T lymphocyte counts and high SAA levels.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.jdiacomp.2020.107666DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323648PMC
October 2020

Radiation-induced second primary squamous cell carcinoma of the oral cavity after radiotherapy for nasopharyngeal carcinoma.

Authors:
Chao Liu Lieqiang Liao Guoying Wu Honghong Yan Xiaoqi Chen Chao Wang Xiajing Zheng Ziyi Zeng Zheng Zhao Di Wu Xuekui Liu

Oral Oncol 2020 Jun 27;109:104863. Epub 2020 Jun 27.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, PR China. Electronic address:

Background: The increasing occurrence of radiation-induced second primary squamous cell carcinoma of the oral cavity (RISCCO) after radiotherapy for nasopharyngeal carcinoma (NPC) has become a noteworthy complication that can influence long-term survival. This study aimed to analyze the associations of clinicopathologic characteristics with prognostic factors among patients who developed RISCCO after radiotherapy for NPC.

Methods: A total of 41,446 NPC patients admitted to Sun Yat-sen University Cancer Center (SYSUCC) between August 1989 and January 2019 were reviewed. Among these patients, 88 RISCCO patients who satisfied the inclusion criteria were included in the study.

Results: During our study, the incidence of RISCCO after radiotherapy was 0.21% (88/41,446) among NPC patients at SYSUCC. The latency period ranged from 1.0 to 34.0 years (median, 9.0 years), and the latency of RISCCO was notably shorter for patients who received intensity-modulated radiation therapy than that for patients who received conventional radiotherapy using cobalt-60 or 6-MV X-rays (median, 4.0 years vs. 11.0 years, P = 0.013). The 1-, 3-, and 5-year overall survival (OS) rates for the entire cohort of 88 patients were 79.0%, 46.6%, and 35.2%, respectively. The 5-year OS rate for the 79 patients who received treatment was 45.7%, and the 5-year OS rate for the 9 patients who refused treatment was 0%. T classification and surgery were identified as independent prognostic factors associated with a high OS rate.

Conclusions: Surgery as the first-choice treatment may improve survival and prognosis. A long-term follow-up is needed for early detection of RISCCO in NPC patients.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.oraloncology.2020.104863DOI Listing
June 2020

DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.

Authors:
Lianqun Zhang Shengli Zhou Ertao Guo Xiaoqi Chen Jun Yang Xiuling Li

Pflugers Arch 2020 08 12;472(8):1041-1049. Epub 2020 Jun 12.

Department of Gastroenterology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, No. 7 Weiwu Road, Zhengzhou, 450003, Henan, China.

Doublecortin-like kinase 1 (DCLK1) is involved in tumorigenesis, tumor growth and metastasis, and epithelial-to-mesenchymal transition in many digestive tract tumors. It is reportedly highly expressed in Barrett's esophagus and esophageal adenocarcinoma, but its effects on the occurrence and progression of esophageal squamous cell carcinoma (ESCC) remain unclear. In this study, real-time PCR and western blot analysis confirmed significant upregulation of DCLK1 expression in human ESCC tissues and cell lines. CCK-8 assay showed that transfection with siRNA against DCLK1 (si-DCLK1) markedly inhibited cell proliferation and colony formation in the ESCC cell lines Eca109 and TE1. Transwell assay revealed that si-DCLK1 transfection inhibited the migratory and invasive capacities of Eca109 and TE1 cells. Moreover, si-DCLK1 increased the chemosensitivity of these cells to cisplatin, as indicated by inhibited cell viability and colony formation, and increased ROS and apoptosis in cisplatin-treated cells. Western blot assay revealed that expression of nuclear β-catenin and c-Myc was significantly increased in ESCC tissues and that si-DCLK1 markedly downregulated nuclear β-catenin and c-Myc in Eca109 cells. Treatment with lithium chloride, an activator of β-catenin signaling, partially abolished the si-DCLK1-induced inhibition of proliferation, migration, invasion, and chemoresistance of ESCC cells. These findings suggest that knockdown of DCLK1 may inhibit the progression of ESCC by regulating proliferation, migration, invasion, and chemosensitivity via suppressing the β-catenin/c-Myc pathway, supporting a promising therapeutic target against ESCC.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s00424-020-02415-zDOI Listing
August 2020

Fluorescence imaging-guided multifunctional liposomes for tumor-specific phototherapy for laryngeal carcinoma.

Authors:
Di Wu Zheng Zhao Nan Wang Xinrui Zhang Honghong Yan Xiaoqi Chen Yunyun Fan Weiwei Liu Xuekui Liu

Biomater Sci 2020 Jun 15;8(12):3443-3453. Epub 2020 May 15.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China.

Reliable diagnosis and efficient targeted therapy are important and may lead to the effective treatment of laryngeal carcinoma. Multifunctional nano-theranostic agents demonstrate great potential in tumor theranostic applications. Thus, herein, we report novel targeting multifunctional theranostic nanoparticles, internalized RGD (iRGD)-modified indocyanine green (ICG) encapsulated liposomes (iLIP), for imaging-guided photothermal therapy (PTT) and photodynamic therapy (PDT) for the treatment of laryngeal carcinoma. The iRGD-PEG-DSPE lipid endowed iLIP with high affinity for tumor vascular targeting, tumor-penetration and tumor cell targeting. The in vivo results showed that iLIP exhibited excellent blood circulation and tumor accumulation. iLIP could be spatially and temporally controlled, simultaneously producing hyperthermia and reactive oxygen species as well as a fluorescence-guided effect through ICG to ablate laryngeal carcinoma cells under irradiation from an 808 nm laser. iLIP generated synergistic photodynamic-photothermal cytotoxicity against Hep-2 cells, resulting in the efficient ablation of laryngeal carcinoma. Thus, the iLIP system provides a promising strategy to improve the precision imaging and effective phototherapy for the treatment of laryngeal carcinoma.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1039/d0bm00249fDOI Listing
June 2020

EEG-Controlled Wall-Crawling Cleaning Robot Using SSVEP-Based Brain-Computer Interface.

Authors:
Lei Shao Longyu Zhang Abdelkader Nasreddine Belkacem Yiming Zhang Xiaoqi Chen Ji Li Hongli Liu

J Healthc Eng 2020 11;2020:6968713. Epub 2020 Jan 11.

Key Laboratory for Control Theory & Applications in Complicated Systems, Tianjin University of Technology, Tianjin 300384, China.

The assistive, adaptive, and rehabilitative applications of EEG-based robot control and navigation are undergoing a major transformation in dimension as well as scope. Under the background of artificial intelligence, medical and nonmedical robots have rapidly developed and have gradually been applied to enhance the quality of people's lives. We focus on connecting the brain with a mobile home robot by translating brain signals to computer commands to build a brain-computer interface that may offer the promise of greatly enhancing the quality of life of disabled and able-bodied people by considerably improving their autonomy, mobility, and abilities. Several types of robots have been controlled using BCI systems to complete real-time simple and/or complicated tasks with high performances. In this paper, a new EEG-based intelligent teleoperation system was designed for a mobile wall-crawling cleaning robot. This robot uses crawler type instead of the traditional wheel type to be used for window or floor cleaning. For EEG-based system controlling the robot position to climb the wall and complete the tasks of cleaning, we extracted steady state visually evoked potential (SSVEP) from the collected electroencephalography (EEG) signal. The visual stimulation interface in the proposed SSVEP-based BCI was composed of four flicker pieces with different frequencies (e.g., 6 Hz, 7.5 Hz, 8.57 Hz, and 10 Hz). Seven subjects were able to smoothly control the movement directions of the cleaning robot by looking at the corresponding flicker using their brain activity. To solve the multiclass problem, thereby achieving the purpose of cleaning the wall within a short period, the canonical correlation analysis (CCA) classification algorithm had been used. Offline and online experiments were held to analyze/classify EEG signals and use them as real-time commands. The proposed system was efficient in the classification and control phases with an obtained accuracy of 89.92% and had an efficient response speed and timing with a bit rate of 22.23 bits/min. These results suggested that the proposed EEG-based clean robot system is promising for smart home control in terms of completing the tasks of cleaning the walls with efficiency, safety, and robustness.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1155/2020/6968713DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201509PMC
May 2021

First-Principles Insight into a Ru-Doped SnS Monolayer as a Promising Biosensor for Exhale Gas Analysis.

Authors:
Qianqian Wan Xiaoqi Chen Yingang Gui

ACS Omega 2020 Apr 7;5(15):8919-8926. Epub 2020 Apr 7.

College of Engineering and Technology, Southwest University, Chongqing 400715, China.

Realizing the diagnosis of lung cancer at an inchoate stage is significant to get valuable time to conduct curative surgery. In this work, we relied on a density functional theory (DFT)-proposed Ru-SnS monolayer as a novel, promising biosensor for lung cancer diagnosis through exhaled gas analysis. The results indicated that the Ru-SnS monolayer has admirable adsorption performance for three typical volatile organic compounds (VOCs) of lung cancer patients, which therefore results in a remarkable change in the electronic behavior of the Ru-doped surface. As a consequence, the conductivity of the Ru-SnS monolayer increases after gas adsorption based on frontier molecular orbital theory. This provides the possibility to explore the Ru-SnS monolayer as a biosensor for lung cancer diagnosis at an early stage. In addition, the desorption behavior of three VOCs from the Ru-SnS surface is studied as well. Our calculations aim at proposing novel sensing nanomaterials for experimentalists to facilitate the progress in lung cancer prognosis.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1021/acsomega.0c00651DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178777PMC
April 2020

Near-Complete Genome Sequence of a Fish Nervous Necrosis Virus Isolated from Hybrid Grouper in China.

Authors:
Peng Jia Xiaoqi Chen Jiajie Fu Meisheng Yi Wenbo Chen Kuntong Jia

Microbiol Resour Announc 2020 Apr 9;9(15). Epub 2020 Apr 9.

School of Marine Sciences, Sun Yat-sen University, Guangzhou, Guangdong, China

The genome sequence of nervous necrosis virus strain HGN1910, isolated from hybrid grouper (♀ × ♂), was cloned, sequenced, and characterized. Two near-complete gene segments were obtained, RNA1 and RNA2. Phylogenetic analysis shows that the virus belongs to the red-spotted grouper nervous necrosis virus genotype of betanodavirus.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1128/MRA.01453-19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380520PMC
April 2020

Process evaluation of a workplace-based health promotion and exercise cluster-randomised trial to increase productivity and reduce neck pain in office workers: a RE-AIM approach.

Authors:
Alyssa Welch Genevieve Healy Leon Straker Tracy Comans Shaun O'Leary Markus Melloh Gisela Sjøgaard Michelle Pereira Xiaoqi Chen Venerina Johnston

BMC Public Health 2020 Feb 4;20(1):180. Epub 2020 Feb 4.

RECOVER Injury Research Centre, The University of Queensland, Brisbane, 4072, Australia.

Background: This study uses the RE-AIM framework to provide a process evaluation of a workplace-based cluster randomised trial comparing an ergonomic plus exercise intervention to an ergonomic plus health promotion intervention; and to highlight variations across organisations; and consider the implications of the findings for intervention translation.

Method: This study applied the RE-AIM (reach, effectiveness, adoption, implementation, maintenance) methodology to examine the interventions' implementation and to explore the extent to which differences between participating organisations contributed to the variations in findings. Qualitative and quantitative data collected from individual participants, research team observations and organisations were interrogated to report on the five RE-AIM domains.

Results: Overall reach was 22.7% but varied across organisations (range 9 to 83%). Participants were generally representative of the recruitment pool though more females (n = 452 or 59%) were recruited than were in the pool (49%). Effectiveness measures (health-related productivity loss and neck pain) varied across all organisations, with no clear pattern emerging to indicate the source of the variation. Organisation-level adoption (66%) and staffing level adoption (91%) were high. The interventions were implemented with minimal protocol variations and high staffing consistency, but organisations varied in their provision of resources (e.g. training space, seniority of liaisons). Mean adherence of participants to the EET intervention was 56% during the intervention period, but varied from 41 to 71% across organisations. At 12 months, 15% of participants reported regular EET adherence. Overall mean (SD) adherence to EHP was 56% (29%) across organisations during the intervention period (range 28 to 77%), with 62% of participants reporting regular adherence at 12 months. No organisations continued the interventions after the follow-up period.

Conclusion: Although the study protocol was implemented with high consistency and fidelity, variations in four domains (reach, effectiveness, adoption and implementation) arose between the 14 participating organisations. These variations may be the source of mixed effectiveness across organisations. Factors known to increase the success of workplace interventions, such as strong management support, a visible commitment to employee wellbeing and participant engagement in intervention design should be considered and adequately measured for future interventions.

Trial Registration: ACTRN12612001154897; 29 October 2012.
View Article and Find Full Text PDF

Download full-text PDF

 Source
http://dx.doi.org/10.1186/s12889-020-8208-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001341PMC
February 2020
-->